Metraipolis › archive › dc_0c8ad90fcf4c

Mauriac Syndrome: Growth and Clinical Outcomes After 2.5 Years of Automated Insulin Delivery Treatment — Europe PMC PMID:41560719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41560719
DOI
10.1210/jcemcr/luaf282
License (as archived)
solo-consultazione
Archived
2026-11-06T17:20:00.466Z
SHA-256 of the archived text
571eb64939c3a1b6e21b798c0355a0505b7d1bffb20dbe2179482ec95ddb53fe
Stable URL of this page
https://metraipolis.com/documento/dc_0c8ad90fcf4c

How to cite

Mauriac Syndrome: Growth and Clinical Outcomes After 2.5 Years of Automated Insulin Delivery Treatment — Europe PMC PMID:41560719 — Europe PMC (en), https://europepmc.org/article/MED/41560719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c8ad90fcf4c (Metraipolis archive dc_0c8ad90fcf4c, sha256 571eb64939c3a1b6e21b798c0355a0505b7d1bffb20dbe2179482ec95ddb53fe)
BibTeX
@misc{dc0c8ad90fcf4c,
  title = {Mauriac Syndrome: Growth and Clinical Outcomes After 2.5 Years of Automated Insulin Delivery Treatment — Europe PMC PMID:41560719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41560719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c8ad90fcf4c; sha256 571eb64939c3a1b6e21b798c0355a0505b7d1bffb20dbe2179482ec95ddb53fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41560719. Agents can read the archived copy with the MCP tool read_document.